All In Biotech

Free tool

FAERS Monitor: Hemabate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017989 or its brand name (Hemabate, Carboprost Tromethamine). Reports on generic versions are filed under their own applications.

Reports

734

Serious

702

96% of reports

Hospitalization

77

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vomiting224
  • nausea199
  • diarrhoea144
  • off label use144
  • abdominal pain upper102
  • chest discomfort95
  • abdominal pain71
  • abdominal discomfort69
  • dyspnoea67
  • blood pressure increased63
  • hyperhidrosis41
  • palpitations41
  • gastrointestinal disorder40
  • headache38
  • dizziness37

Reports by year received

View as table
YearReports
20043
20054
20061
20072
20095
20102
20113
20125
20137
20143
20154
20169
20177
201812
201919
202033
202190
2022138
2023131
2024121
202583
202652

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,425 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chest discomfortSignal9526.622.12,325
abdominal pain upperSignal10214.211.91,250
vomitingSignal22413.712.22,674
gastrointestinal disorderSignal4012.89.5425
blood pressure increasedSignal6311.89.3617
abdominal discomfortSignal6911.89.4676
palpitationsSignal4110.07.5326
hyperhidrosisSignal419.16.8290
abdominal painSignal718.77.0485
nauseaSignal1997.26.41,099
diarrhoeaSignal1446.45.5670
off label useSignal1444.74.1436
dyspnoeaSignal673.42.7114
dizzinessSignal372.11.621
headache381.71.311

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.